|
1
|
Mundy GR: Metastasis to bone: Causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wiens M, Wang X, Schlossmacher U,
Lieberwirth I, Glasser G, Ushijima H, Schröder HC and Müller WE:
Osteogenic potential of biosilica on human osteoblast-like (SaOS-2)
cells. Calcify Tissue Int. 87:513–524. 2010. View Article : Google Scholar
|
|
3
|
Thouverey C, Strzelecka-Kiliszek A,
Balcerzak M, Buchet R and Pikula S: Matrix vesicles originate from
apical membrane microvilli of mineralizing osteoblast-like Saos-2
cells. J Cell Biochem. 106:127–138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang N, Ying MD, Wu YP, Zhou ZH, Ye ZM,
Li H and Lin DS: Hyperoside, a flavonoid compound, inhibits
proliferation and stimulates osteogenic differentiation of human
osteosarcoma cells. PLoS One. 9:e989732014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanagata N, Li X, Morita H, Takemura T, Li
J and Minowa T: Characterization of the osteoblast-specific
transmembrane protein IFITM5 and analysis of IFITM5-deficient mice.
J Bone Miner Metab. 29:279–290. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moffatt P, Gaumond MH, Salois P, Sellin K,
Bessette MC, Godin E, de Oliveira PT, Atkins GJ, Nanci A and Thomas
G: Bril: A novel bone-specific modulator of mineralization. J Bone
Miner Res. 23:1497–1508. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegrist F, Ebeling M and Certa U: The
small interferon-induced transmembrane genes and proteins. J
Interferon Cytokine Res. 31:183–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Semler O, Garbes L, Keupp K, Swan D,
Zimmermann K, Becker J, Iden S, Wirth B, Eysel P, Koerber F, et al:
A mutation in the 50-UTR of IFITM5 creates an in-frame start codon
and causes autosomal-dominant osteogenesis imperfecta type V with
hyperplastic callus. Am J Hum Genet. 91:349–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ,
Jeon D, Lee G, Kim HN, Lee HR, Eom HH, et al: A single recurrent
mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta
type V. Am J Hum Genet. 91:343–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reich A, Bae AS, Barnes AM, Cabral WA,
Hinek A, Stimec J, Hill SC, Chitayat D and Marini JC: Type V OI
primary osteoblasts display increased mineralization despite
decreased COL1A1 expression. J Clin Endocrinol Metab.
100:E325–E332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Noda M and Denhardt DT: Regulation of
osteopontin gene expression in osteoblasts. Ann N Y Acad Sci.
760:242–248. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu PP, Leung KS, Kumta SM, Lee KM and
Fung KP: Bone-specific alkaline phosphatase in plasma as tumour
marker for osteosarcoma. Oncology. 53:275–280. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pensak MJ and Lieberman JR: Gene therapy
for bone regeneration. Curr Pharm Des. 19:3466–3473. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Glass DA II and Karsenty G: In vivo
analysis of Wnt signaling in bone. Endocrinology. 148:2630–2634.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo P, Yang X, Ying M, Chaudhry P, Wang A,
Shimada H, May WA, Adams GB, Mock D, Triche TJ, et al:
Retinoid-suppressed phosphorylation of RARalpha mediates the
differentiation pathway of osteosarcoma cells. Oncogene.
29:2772–2783. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Testi AM, Biondi A, Lo Coco F, Moleti ML,
Giona F, Vignetti M, Menna G, Locatelli F, Pession A, Barisone E,
et al: GIMEMA-AIEOPAIDA protocol for the treatment of newly
diagnosed acute promyelocytic leukemia (APL) in children. Blood.
106:447–453. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pitha-Rowe I, Petty WJ, Kitareewan S and
Dmitrovsky E: Retinoid target genes in acute promyelocytic
leukemia. Leukemia. 17:1723–1730. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gobin B, Moriceau G, Ory B, Charrier C,
Brion R, Blanchard F, Redini F and Heymann D: Imatinib mesylate
exerts anti-proliferative effects on osteosarcoma cells and
inhibits the tumour growth in immunocompetent murine models. PLoS
One. 9:e907952014. View Article : Google Scholar : PubMed/NCBI
|
